EUVIMEDEUVIMED entdecken
Crossref

Threat of respiratory syncytial virus infection knocking the door: a proposed potential drug candidate through molecular dynamics simulations, a future alternative

Debanjan Mitra, Shagufta Afreen, Pradeep K Das Mohapatra, Mohnad Abdalla

Journal of Molecular Modeling · 2023

DOI: 10.1007/s00894-023-05489-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Modeling, 2023. Verfasst von Debanjan Mitra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Microbiology, Raiganj University, Raiganj, WB, 733134, India. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery of antiviral approaches to prevent or cure respiratory syncytial virus (RSV) infections is critical, particularly because RSV is one of the most common causes of infant respiratory problems. There is currently no approved vaccination available to treat RSV infections. FDA has approved the drug ribavirin, but it is not sufficient to treat RSV. This work aimed to find and study in silico anti-RSV drugs that target matrix protein and nucleoprotein. In this study, we have identified five drug candidates that had better binding energies than ribavirin. Garenoxacin appeared as top lead compounds between them. AutoDock Vina was used to execute molecular docking of a library of chosen chemicals. The high-score compound was then confirmed using the Maestro 12.3 module's molecular dynamics simulation and the binding energies derived using Prime/Molecular Mechanics Generalized Born Surface Area (Prime/MM-GBSA). Comparative molecular dynamics simulations revealed that garenoxacin has better stability and high residue contacts with high binding affinity than ribavirin. This study showed garenoxacin could prevent RSV infection better than ribavirin. In pursuing a more effective RSV control drug, additional research into these chemicals in vitro and in vivo is essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsHumansRibavirinMolecular Dynamics SimulationMolecular Docking SimulationAntiviral Agents

Stichwörter der Autor:innen

GarenoxacinMolecular dynamics simulationRespiratory syncytial virusRibavirin

Substanzen

RibavirinAntiviral Agents

Autor:innen und Institutionen

  • Dept. of Microbiology, Raiganj University, Raiganj, WB, 733134, India.
  • CAS Key laboratory of Biobased material, Qingdao Institute of Bioenergy and Bioprocess Technology Chinese Academy of Sciences, Qingdao, Shandong, 266101, People's Republic of China.
  • Dept. of Microbiology, Raiganj University, Raiganj, WB, 733134, India. pkdmvu@gmail.com.
  • Pediatric Research Institute, Children's Hospital Affiliated to Shandong University, Jinan, Shandong, 250022, People's Republic of China. mohnadabdalla200@gmail.com.

Zitieren

APA

Mitra, D., Afreen, S., Das Mohapatra, P. K., & Abdalla, M. (2023). Threat of respiratory syncytial virus infection knocking the door: a proposed potential drug candidate through molecular dynamics simulations, a future alternative. Journal of Molecular Modeling. https://doi.org/10.1007/s00894-023-05489-5

Vancouver

Mitra D, Afreen S, Das Mohapatra PK, Abdalla M. Threat of respiratory syncytial virus infection knocking the door: a proposed potential drug candidate through molecular dynamics simulations, a future alternative. Journal of Molecular Modeling. 2023. doi:10.1007/s00894-023-05489-5

BibTeX
@article{Mitra2023,
  author = {Mitra, Debanjan and Afreen, Shagufta and Das Mohapatra, Pradeep K and Abdalla, Mohnad},
  title = {Threat of respiratory syncytial virus infection knocking the door: a proposed potential drug candidate through molecular dynamics simulations, a future alternative},
  journal = {Journal of Molecular Modeling},
  year = {2023},
  doi = {10.1007/s00894-023-05489-5}
}
Kostenlos starten →